APSR2026-300

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-037
P56
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1207170-46904-APSR Lung (1)_432790.pdf
Format: PDF Only
08. Lung Cancer
5

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Shu Feng Tan * Hospital Pulau Pinang Department of Respiratory Medicine Georgetown Malaysia
Lalitha Pereirasamy - Hospital Pulau Pinang Department of Respiratory Medicine Georgetown Malaysia
Irfhan Ali Hyder Ali - Hospital Pulau Pinang Department of Respiratory Medicine Georgetown Malaysia
Umadevi A. Muthukumaru - Hospital Pulau Pinang Department of Respiratory Medicine Georgetown Malaysia
Minalosani Arumugam - Hospital Pulau Pinang Department of Respiratory Medicine Georgetown Malaysia
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Shu Feng
Tan
tansf888@gmail.com
+60178720728
31-40
Malaysia
Case Report
Rapid ventilator liberation and radiological resolution following crizotinib therapy in ros1-positive lung adenocarcinoma mimicking severe tuberculous pneumonia
Maximum 25 words
Abstract Content
 
 
 
 
Lung adenocarcinoma can occasionally present with diffuse pulmonary infiltrates mimicking severe tuberculosis, leading to diagnostic delay, particularly in endemic regions. Molecular profiling is essential as targeted therapy can lead to rapid clinical improvement.
A 60-year-old Chinese gentleman, non-smoker with underlying diabetes mellitus, presented with a four-month history of chronic cough, associated with intermittent fever and unintentional weight loss of 5 kg. He was initially admitted with community-acquired pneumonia complicated by type 1 respiratory failure. Chest radiograph demonstrated right upper lobe opacity with air bronchograms. In view of the radiological finding and the endemic tuberculosis setting, pulmonary tuberculosis was suspected and empirical anti-tuberculosis therapy was initiated. Computed tomography pulmonary angiography excluded pulmonary embolism but showed persistent right upper lobe consolidation with diffuse lung parenchymal changes suggestive of infection. His condition deteriorated with progressive hypoxemia requiring endotracheal intubation and intensive care unit admission. Bronchoscopy revealed normal airway mucosa without endobronchial lesions. Bronchoalveolar lavage analysis, including acid-fast bacilli smear, TB GeneXpert, cytology, and microbiological studies, was unremarkable. Despite prolonged anti-tuberculosis therapy and broad-spectrum antibiotics, there was no clinical or radiological improvement. After one month of mechanical ventilation, a CT-guided lung biopsy was expedited. Histopathology demonstrated moderately differentiated lung adenocarcinoma. Next-generation sequencing identified a ROS1 gene fusion. Anti-tuberculosis therapy was discontinued and targeted therapy with crizotinib was commenced. Following initiation of crizotinib, the patient showed marked clinical improvement and was successfully extubated two months later, with significant radiological resolution of the right upper lobe consolidation. He was subsequently transferred back to the respiratory ward.
This case underscores the importance of maintaining a broad differential diagnosis in patients with non-resolving pneumonia. Early tissue diagnosis and comprehensive molecular testing are essential to facilitate timely initiation of targeted therapy, which may significantly improve outcomes even in severe clinical presentations.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
lung adenocarcinoma,ros1 positive,crizotinib
maximum 3 keywords and no abbreviations, separated by commas
Nothing for disclosure
292